Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

In the company’s first-quarter earnings call Tuesday, J&J CEO Joaquin Duato said there’s a better way to encourage drug ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

Divi's Labs said it will invest Rs 650-700 crore in capacity expansion and that it eyes significant revenue boost ...

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

The Illinois expansion will happen at the company’s headquarter campus in Abbott Park. It's also growing in Dallas.

LGM Pharma has announced plans to expand its manufacturing facility in Rosenberg, Texas. The company, which provides tailored ...

With extensive experience in manufacturing APIs, advanced intermediates and specialty chemicals, SCI Pharmtech is one of ...